DurgicalDurgical
EN
Open the app

Glipizide !

A shorter-acting sulfonylurea taken before meals. Its inactive metabolites make it a common choice when kidney function is reduced.

Updated 2026-11-01

  • Class: Sulfonylureas
  • Ion channel: Sulfonylurea receptor 1 (SUR1) of the KATP channel
  • ATC code: A10BB07

No structure with this drug is available; the figure shows glibenclamide, another sulfonylurea that binds the same SUR1 pocket of the KATP channel (hamster SUR1, rat Kir6.2).

Target in 3D: Sulfonylurea receptor 1 (SUR1) of the KATP channel. PDB structure 6BAA (RCSB PDB, public domain). View the structure at RCSB PDB

Mechanism of action

Glipizide closes the beta-cell KATP channel through SUR1, so calcium enters and insulin is released. It acts faster and for a shorter time than glibenclamide, and is converted in the liver to inactive metabolites.

  1. Binds SUR1 on the beta-cell KATP channel
  2. The channel closes and the membrane depolarizes
  3. Calcium channels open and insulin granules are released
  4. Glucose falls, even when it is already low

Pharmacokinetics

Absorption
Oral; regular tablets are taken before meals; an extended-release form also exists.
Metabolism
In the liver to inactive metabolites.
Elimination
Metabolites leave mainly in urine.

Indications

Adverse effects

Common

  • Hypoglycemia
  • Weight gain
  • Nausea, diarrhea, dizziness

Contraindications

  • Hypersensitivity to glipizide
  • Type 1 diabetes and diabetic ketoacidosis

Key interactions

Insulin and other glucose-lowering drugs
Add to hypoglycemia.
Beta-blockers
Can increase the effect and blunt the warning signs of hypoglycemia.
NSAIDs and salicylates, sulfonamides, fluoroquinolones, oral azole antifungals (miconazole)
Can increase the glucose-lowering effect and cause severe hypoglycemia.
Alcohol
Raises the risk of hypoglycemia.
Cimetidine
Can increase the glucose-lowering effect.

What is monitored

  • Capillary glucose
  • HbA1c
  • Kidney and liver function

Administration and safety

  • Oral tablet, given with a meal (usually breakfast); a skipped meal raises hypoglycemia risk.
  • Look-alike names: glipizide, glyburide (glibenclamide) and glimepiride are easily confused.
  • Often held while the patient is fasting (nil by mouth) in hospital.

Nursing care

  • Before: capillary glucose, kidney and liver function, meal intake, age.
  • During: signs of hypoglycemia (sweating, tremor, confusion); beta-blockers can mask them.
  • After a hypoglycemia episode: glucose is rechecked for many hours, because it can come back.
  • Teach: carry fast sugar, avoid skipping meals, limit alcohol.

Pregnancy and breastfeeding

Insulin is the usual choice. A sulfonylurea taken near delivery can cause prolonged hypoglycemia in the newborn.

Test yourself

Think of the answer, then tap the question to see it.

Why is glipizide often chosen over glibenclamide when kidney function is reduced?

Its metabolites are inactive and its action shorter, so it accumulates less and causes less prolonged hypoglycemia.

When is the regular glipizide tablet given in relation to meals?

Before meals, so the insulin release matches the meal.

Which hormone deficiencies raise the risk of severe hypoglycemia on glipizide?

Adrenal and pituitary insufficiency, because cortisol and growth hormone normally help defend glucose.

Add to my cards (3)

← Back to the class: Sulfonylureas

Educational content on how drugs work; not a prescribing guide and no substitute for a health professional's advice. No doses are given.

Sources: Glipizide: MedlinePlus Drug Information (MedlinePlus (U.S. National Library of Medicine), 2026); DailyMed - GLIPIZIDE tablet (DailyMed (U.S. National Library of Medicine), 2026); ATCDDD - ATC/DDD Index (WHO Collaborating Centre for Drug Statistics Methodology, 2026).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.